Cooperative Agreement R01DA031142

This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $885,824 aims to assess consumer response to smokeless tobacco modified risk marketing orders. The research activities will explore 1) consumers' exposure and reactions to authorized smokeless tobacco modified risk tobacco product (MRTP) claims, and 2) whether the MRTP claims influence smokeless tobacco demand and sensory evaluations. The project will be conducted...

Federal Grant Award Summary Health Research, Inc.'s Roswell Park Division received a $816,307 project grant from the National Institutes of Health under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), effective September 15, 2025, through August 31, 2030. The award funds a comprehensive regulatory science research initiative designed to assess the impact of the substantial equivalence (SE) mechanism on cigarette and cigar markets. The research...

Federal Grant Award Summary The Office of the Director awarded a $1,197,896 Project Grant to the University of Oklahoma Health Sciences Center (OUHSC) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) to conduct a longitudinal research study examining the impact of electronic nicotine delivery system (ENDS) product characteristics on use behaviors among young adults. The five-year award, effective May 1, 2025 through April 30, 2030, supports...

The National Institute on Drug Abuse (NIDA) awarded a $639,920 Project Grant on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a human laboratory study examining the influence of "natural" cigarillo descriptors on consumer expectancies, subjective effects, smoking behavior, and toxicant exposure. The project, titled "Understanding the Influence of 'Natural' Cigarillo Descriptors on Expectancies, Subjective Effects, Smoking Behavior,...

Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pennsylvania a $663,554 Project Grant on August 18, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct research on smoking cessation interventions targeting individuals unmotivated or unready to quit smoking (PUQS). The primary deliverable is a research study examining harm reduction product sampling as a pragmatic approach to catalyze smoking behavior change. Rather...

This Project Grant award of $320,000 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a smoking and vaping cessation treatment based on the drug candidate cytisine. The goal is to explore the feasibility of delivering cytisine through electronic vape administration (EVA) to help stabilize dopamine release and reduce nicotine self-administration in a mouse model of nicotine addiction. Key activities include...

Federal Grant Award Summary The Ohio State University received a $186,281 Project Grant from the National Institutes of Health under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), effective August 1, 2025 through July 31, 2030. This K01 mentored career development award supports a novel tobacco regulatory science study examining the abuse liability and substitutability of synthetic coolants for menthol in cigarettes. The research will employ a...

The Society for Research on Nicotine and Tobacco (SRNT) received a $150,000 project grant award from the U.S. Department of Health and Human Services Food and Drug Administration (FDA) under the FDA Research program (CFDA 93.103) to support the SRNT 2021 Annual Meeting. The SRNT Annual Meeting is the premier conference in the field of nicotine and tobacco research, bringing together over 1,200 investigators, advocates, and policymakers from over 40 countries annually. Through this January 2021...

This R21 Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $433,950 to the University of California, Davis to study the impact of wildfire smoke exposure on lung injury and disease in pediatric populations. The key objectives are to: 1) Define the contribution of age on the toxicity of wood smoke particles in respiratory and alveolar epithelium, 2) Investigate the effect of early life wood...

Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded Rutgers The State University of New Jersey – Robert Wood Johnson Medical School (RBHS) School of Nursing a $687,511 Project Grant on August 14, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a randomized controlled trial examining charcoal-filtered cigarettes, specifically the Natural American Spirit brand's "Sky" product. The five-year project, extending through...